Evolent Health, Inc.EVHNYSE
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-4.86%
↑ 97% above average
Average (39q)
-141.57%
Historical baseline
Range
High:146.27%
Low:-2881.60%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -4.86% |
| Q2 2025 | 69.21% |
| Q1 2025 | -183.39% |
| Q4 2024 | 1.45% |
| Q3 2024 | -1549.69% |
| Q2 2024 | 109.24% |
| Q1 2024 | 48.28% |
| Q4 2023 | -31.93% |
| Q3 2023 | 26.22% |
| Q2 2023 | -71.77% |
| Q1 2023 | -76.07% |
| Q4 2022 | -634.57% |
| Q3 2022 | 146.27% |
| Q2 2022 | 14.24% |
| Q1 2022 | 5.26% |
| Q4 2021 | 56.69% |
| Q3 2021 | -43.19% |
| Q2 2021 | 7.14% |
| Q1 2021 | 32.94% |
| Q4 2020 | 60.84% |
| Q3 2020 | 81.65% |
| Q2 2020 | -158.43% |
| Q1 2020 | 60.25% |
| Q4 2019 | -676.21% |
| Q3 2019 | 19.28% |
| Q2 2019 | 32.36% |
| Q1 2019 | -180.09% |
| Q4 2018 | -34.26% |
| Q3 2018 | -25.34% |
| Q2 2018 | 27.23% |
| Q1 2018 | -3.54% |
| Q4 2017 | -4.54% |
| Q3 2017 | 25.54% |
| Q2 2017 | 6.15% |
| Q1 2017 | -3.48% |
| Q4 2016 | -55.31% |
| Q3 2016 | -33.64% |
| Q2 2016 | 93.17% |
| Q1 2016 | -2881.60% |
| Q4 2015 | 65.62% |